- Global Pharma News & Resources

Closing of Biotage's Acquisition of Horizon Technology

Biotage AB (Biotage), (NASDAQ OMX Stockholm: BIOT.ST) today announces the closing of the acquisition of all outstanding shares in the privately held company Horizon Technology, Inc. (Horizon) based in New Hampshire, US, in accordance with contract and public announcement of December 6th, 2017. The purchase price adjusted for actual net cash at the closing date is approx. USD 17.9 million, corresponding to approx. SEK 143.4 million[1], based on an enterprise value of approx. USD 16.4 million and cash of approx. USD 1.5 million.

This information was submitted for publication, through the agency of the contact persons set out above, at 17.00 CET on January 16, 2018.

[1] Based on an exchange rate USD/SEK of 0.1247. This exchange rate has been used throughout this press release for the conversion of USD/SEK.